Reports
Reports
Sale
The global chronic lower back pain treatment market size was estimated to be worth USD 8.29 billion in 2023. The market is expected to rise at a CAGR of 4.9% in the forecast period of 2024-2032, and by 2032, the market value is anticipated to be worth USD 12.75 billion. The rise in the neurological disorders and the sedentary lifestyle of the people are the primary market drivers.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Chronic lower back pain is a type of back pain which lasts for a period of twelve weeks and more. This pain continues to persist even after the treatment of acute lower back pain.
Numerous factors account for the aetiology of chronic lower back pain. The main causes of chronic lower back pain are congenital disorders, injuries, degenerative problems, nerve and spinal cord problems. These all causes are mechanical in nature.
The congenital causes include skeletal disorders and spina bifida. Sprains or any type of traumatic injury are also responsible for chronic lower back pain. The non-spinal causes of chronic lower back pain include kidney stones, endometriosis, tumours, fibromyalgia, and pregnancy.
The risk factors of chronic lower back pain include increasing age, smoking, and genetic and psychological factors. Improper lifestyle patterns and improper postures significantly increase the chances of chronic lower back pain.
The diagnosis and management of chronic lower back pain account for the chronic lower back pain treatment market. The diagnostic tests include blood tests, bone scans, and discography. Diagnostic imaging tests, such as computerised tomography, magnetic resonance imaging, and X-ray imaging are also used to assess the body’s anatomy.
Chronic lower back pain is treated through a proper step-by-step procedure. The treatment begins with the essential medications with more effective and advanced approaches.
According to the chronic lower back pain treatment market research report, the market can be categorised into the following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Pain Type
Market Breakup by Diagnosis
Market Breakup by Treatment Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of neurological disorders drives the growth of the chronic lower back pain treatment market. The neurological system consists of the brain and spinal cord, so it directly affects the lower back and cause sensations that stimulate lower back pain. Inactive lifestyle patterns are also contributing to lower back pain.
The increased adoption of painkillers for all pain types also stimulate the market growth to a significant extent. The increased sales of painkillers will facilitate the generation of more significant revenues, aiding the expansion of the market.
Additional factors aiding the growth of the market include the rising incidence of lower back pain cases, increasing healthcare expenditure, and better awareness. According to the National Institute of Neurological disorders and stroke, around 80% of adults experience acute or chronic lower back pain discomfort once in a lifetime.
North American regional market is dominating the chronic lower back pain treatment market owing to the advanced healthcare infrastructure, rising prevalence, and increasing research and development activities.
The Asia Pacific region is anticipated to be the fastest growing region due to increasing developmental activities and the rising geriatric population.
Chronic lower back pain is the most prevalent chronic pain disorder. The neuropathic component is responsible for the chronic pain and the rising prevalence of other comorbidities.
The exact cause or mechanism of chronic lower back pain is not known. Due to this, there are no universally accepted therapeutic interventions. The main aim of the treatment is to alleviate the symptoms and reduce the intensity of pain. For the management of pain, several options are available in the chronic lower back pain treatment market.
Chronic lower back pain treatment initiates with anti-inflammatory medications. The physician may also prescribe anticonvulsants, antidepressants, and opioid drugs to manage chronic pain. Along with this, self-management techniques like hot or cold packs and physical exercises can also be incorporated into the treatment schedule for more effective results.
Complementary and alternative management techniques like acupuncture, transcutaneous electrical nerve stimulation, spinal mobilisation and physical therapy programs are used to restore mobility and reduce pain sensations. Spinal injections carrying suitable medications can also be given for immediate pain relief.
Surgical procedures are considered for specific indications when the above treatment methods fail. The different surgeries for management of chronic lower back pain are vertebroplasty, spinal laminectomy, discectomy, foraminotomy and nucleoplasty.
Over the last decade, developments in back pain therapies have accelerated and resulted in multiple effective treatment options. These novel therapies and strategies have grabbed the attention of the key players. This will assist in the growth of the chronic lower back pain treatment market.
Technological advancements and extensive clinical research contribute to discovering more innovative therapeutic methods. The trials for the novel medications are under process and, once completed, will lead to the development of novel targeted therapies.
A randomised clinical trial was performed by the scientists of the United States, Europe, and Australia to assess the efficacy of their novel method called RESOLVE. This new program is called the graded sensorimotor retraining intervention. In this program, brain-back communication is improved by retraining the brain. The results suggested that this helps decrease the pain intensity of the lower back.
Eli Lilly and Company, one of the leading key players, is also performing Phase II clinical trials for its novel medication that effectively manages chronic back pain. This drug acts by blocking the potent cation channels, thus suppressing the pain sensations.
The incorporation of advanced technologies has also stimulated the development of effective treatments. Abbott, a key player, has successfully performed clinical trials for its new Proclaim Plus spinal cord stimulation system. This system will mimic the natural patterns found in the brain and will assist in pain management.
Several ongoing clinical trials are emerging as a driving factor for chronic lower back pain treatment market growth and development.
The report gives an in-depth analysis of the key players involved in the market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Pain Type |
|
Breakup by Diagnosis |
|
Breakup by Treatment Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Chronic Lower Back Pain Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Drug Development to Commercial Launch
6.2.1.3 New Drug Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Chronic Lower Back Pain Treatment Market
8.1 Global Chronic Lower Back Pain Treatment Market Overview
8.2 Global Chronic Lower Back Pain Treatment Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Chronic Lower Back Pain Treatment Market Historical Value (2017-2023)
8.2.1.2 Global Chronic Lower Back Pain Treatment Market Forecast Value (2024-2032)
8.3 Global Chronic Lower Back Pain Treatment Market by Pain Type
8.3.1 Market Overview
8.3.1.1 Discogenic Pain
8.3.1.2 Lumbar Spinal Stenosis
8.3.1.3 Sacroiliac Pain
8.3.1.4 Facet- Joint Pain
8.3.1.5 Radicular Pain
8.3.1.6 Muscular Pain
8.3.1.7 Others
8.4 Global Chronic Lower Back Pain Treatment Market by Diagnosis
8.4.1 Market Overview
8.4.1.1 Clinical History
8.4.1.2 Physical Examination
8.4.1.3 Imaging Guidelines
8.4.1.4 Others
8.5 Global Chronic Lower Back Pain Treatment Market by Treatment Channel
8.5.1 Market Overview
8.5.1.1 Public
8.5.1.2 Private
8.6 Global Chronic Lower Back Pain Treatment Market by Region
8.6.1 Market Overview
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Middle East and Africa
8.6.1.5 Latin America
9 North America Chronic Lower Back Pain Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 Canada
9.3.1 Historical Trend (2017-2023)
9.3.2 Forecast Trend (2024-2032)
10 Europe Chronic Lower Back Pain Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 Germany
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 France
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Italy
10.5.1 Historical Trend (2017-2023)
10.5.2 Forecast Trend (2024-2032)
10.6 Others
11 Asia Pacific Chronic Lower Back Pain Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 Japan
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 India
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 ASEAN
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Australia
11.6.1 Historical Trend (2017-2023)
11.6.2 Forecast Trend (2024-2032)
11.7 Others
12 Latin America Chronic Lower Back Pain Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Argentina
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Mexico
12.4.1 Historical Trend (2017-2023)
12.4.2 Forecast Trend (2024-2032)
12.5 Others
13 Middle East and Africa Chronic Lower Back Pain Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 United Arab Emirates
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 Nigeria
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 South Africa
13.5.1 Historical Trend (2017-2023)
13.5.2 Forecast Trend (2024-2032)
13.6 Others
14 Global Chronic Lower Back Pain Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives, and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Johnson & Johnson
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Pfizer Inc.
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Sanofi S.A.
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Merck & Co., Inc.
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Medtronic plc
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Endo International plc
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Boston Scientific Corporation
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Koninklijke Philips N.V.
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Karl Storz SE & Co. KG
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Stryker Corporation
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Global Chronic Lower Back Pain Treatment Market- Drug Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Based on the pain type, the market is segmented into discogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, and muscular pain, among others.
The different regions in this market are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is anticipated to hold a significant share in the market during the forecast period.
There is no effective treatment for complete eradication, but different therapeutic strategies help alleviate symptoms. Anti-inflammatory medications, acupuncture, physical therapy programs and surgical interventions help alleviate and manage chronic lower back pain.
There are two treatment channels in the market: public and private.
Increasing prevalence of neurological disorders, rising adoption of anti-inflammatory drugs, technological advancements, increased research and developmental activities, and better awareness are the driving factors in the market.
The key companies involved in the market are Johnson & Johnson, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Medtronic plc, Endo International plc, Boston Scientific Corporation, Koninklijke Philips N.V., Karl Storz SE & Co. KG, Stryker Corporation, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.